Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation

Bioorg Med Chem Lett. 2012 Sep 15;22(18):6010-5. doi: 10.1016/j.bmcl.2012.05.019. Epub 2012 May 11.

Abstract

Twenty-six 2-pyridone derivatives (8a-8z), which are structurally analogous to amrinone and milrinone two important cardiotonic drugs, are synthesized and characterized. The synthesis of 2-pyridone derivatives involves addition, followed by cyclization between Baylis-Hillman acetates (7a-7k) and enamino esters or nitriles (3a-3e). Thus synthesized pyridones were subjected to PDE3 inhibitory activity, 14 pyridones were found to be hits out of 26 pyridones synthesized and out of 14 hits, there are 5 pyridones found to be lead compounds having excellent PDE3 inhibitory activity. Further we have carried out computational analysis to understand protein/enzyme and 2-pyridone derivative interactions to identify amino acid residues involved in the vicinity of binding and compared with milrinone drug.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiotonic Agents / chemical synthesis*
  • Cardiotonic Agents / chemistry
  • Cardiotonic Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Heart Failure / drug therapy*
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Phosphodiesterase 3 Inhibitors / chemical synthesis*
  • Phosphodiesterase 3 Inhibitors / chemistry
  • Phosphodiesterase 3 Inhibitors / pharmacology*
  • Platelet Aggregation / drug effects*
  • Pyridones / chemistry
  • Pyridones / pharmacology*
  • Structure-Activity Relationship

Substances

  • Cardiotonic Agents
  • Phosphodiesterase 3 Inhibitors
  • Pyridones
  • 2-hydroxypyridine